Skip to main content

Table 1 Patient’s clinical course

From: Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report

November 2013

January 2014

February–April 2014

April 2014

June–July 2014

Presented with hoarse voice

Tumour resection and diagnosis of FDCS

CHOP chemotherapy

BRCA2 mutation detected

Mediastinal radiotherapy

April 2015

June 2015

July–October 2015

October 2015

February 2016

Disease recurrence

Carboplatin chemotherapy

Concurrent veliparib with carboplatin

Maintenance veliparib

Stable at last follow-up